drugset / Trial / NCT01108744

Double Blind Study of Hypertonic Saline vs Mannitol in the Management of Increased Intracranial Pressure (ICP).

NCT01108744

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study goal is to compare the management of increased intra-cranial pressure (ICP) using 3% hypertonic saline vs. mannitol (given in same osmolar loads). Primary hypothesis: 1\. Hypertonic saline will be non-inferior to mannitol in decreasing elevated ICP. Secondary hypotheses: 1. Hypertonic saline therapy will result with fewer complications than mannitol 2. ICP reduction duration will be longer using hypertonic saline when compared with mannitol

Timeline

Start
2012-01
Primary completion
2014-01
Completion
2014-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hypertonic saline Unknown 3 %
Comparator Mannitol Diagnostic / imaging agent 20 % Intravenous